PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION Mesoblast grants TiGenix an exclusive global patent license to use adiposederived mesenchymal stem cells in the local treatment of fistulae New York USA Melbourne Australia and Leuven Belgium Dece...
↧